NEW YORK, Nov. 2, 2023 /PRNewswire/ — The Preclinical Isolated Organ Perfusion System Market size is expected to grow by USD 137.63 million, accelerating at a CAGR of over 4.86% during the forecast period, according to Technavio Research. Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their market position. The report also offers detailed analyses of the market’s competitive landscape, featuring information on 15 leading companies including ADInstruments Pty Ltd., ALA Scientific Instruments Inc., emka TECHNOLOGIES, Harvard Bioscience Inc., MDE GmbH, Radnoti LLC, World Precision Instruments and XVIVO Perfusion AB. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report
Preclinical Isolated Organ Perfusion System Market 2024 – 2028: Company Profile:
ADInstruments Pty Ltd: The company offers preclinical isolated organ perfusion systems such as the Isolated Perfused Rodent Liver Foundation System which provides the glassware for perfusing an isolated rodent liver to maintain its hepatic function.
- To gain access to more vendor profiles available with Technavio, buy the report
Preclinical Isolated Organ Perfusion System Market 2024 – 2028: Segmentation Analysis
The market is segmented by End-user (Industrial laboratories and CROs and Academic and government research institutes), Type (Isolated heart perfusion systems, Isolated abdominal organ perfusion systems, Isolated lung perfusion systems, and Cell isolation and others), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
The industrial laboratories and Contract Research Organizations (CROs) segment is anticipated for substantial growth during the forecast period. These entities play a significant role in drug discovery, research, design, and development, boasting the necessary infrastructure for conducting preclinical and clinical studies to evaluate different drug candidates. The growth of this segment is driven by the mounting investments made by pharmaceutical companies in drug discovery and the escalating trend of outsourcing activities to CROs.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report
Preclinical Isolated Organ Perfusion System Market 2024 – 2028: Regional Analysis
North America is expected to make a substantial 36% contribution to the global market’s growth during the forecast period. The Preclinical Isolated Organ Perfusion System Market is driven in North America is based on key factors like the presence of leading companies, technological advancements, increased funding and research in life sciences, and the established presence of pharmaceutical companies and research institutes. Key market players such as Harvard Bioscience Inc., Radnoti LLC, and Emka Technologies play a positive role in market growth.
Moreover, the growing adoption of advanced technologies and products, including isolated organ perfusion systems for preclinical research, is a driving force behind the market’s expansion in the region. These elements collectively fuel market growth in North America during the forecast period.
Preclinical Isolated Organ Perfusion System Market 2024 – 2028: Driver & Trend:
- Prevalence of chronic diseases is a key driver for the preclinical isolated organ perfusion system market.
- These systems are crucial for preclinical research focused on organ-specific drug delivery and studying drug impacts on isolated organs.
- Increasing rates of chronic conditions like cancer, cardiovascular, and respiratory diseases fuel market growth.
- Growing demand for new drugs drives drug discovery activities, leading to increased adoption of isolated organ perfusion systems for pharmacological studies.
- These factors are expected to have a positive impact on market growth during the forecast period.
Trend – Increasing investment in R&D and preclinical research is one of the key trends driving the preclinical isolated organ perfusion system market growth.
Identify key trends, drivers, and challenges in the market. Download the sample report to gain access to this information
Organ Preservation Market: The global organ preservation market size is estimated to grow by USD 106.96 million at a CAGR of 6.91% between 2022 and 2027.
Transplant Box Market: The Global Transplant Box Market size is estimated to grow by USD 1,671.02 million at a CAGR of 8.6% between 2022 and 2027.
- Executive Summary
- Market Landscape
- Market Sizing
- Historic Market Sizes
- Five Forces Analysis
- Market Segmentation by End-User
- Market Segmentation by Type
- Market Segmentation by Geography
- Customer Landscape
- Geographic Landscape
- Drivers, Challenges, & Trends
- Company Landscape
- Company Analysis
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]